Teriflunomide

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69339-170
  • Package NDC 69339-170-03
  • Package NDC 69339-170-09
  • Package NDC 69339-170-93
  • Application number ANDA209555
  • SPL ID 70bc9344-abbf-4aca-96c0-7f10cfe9aae4
  • SPL set ID 8219b4a2-fb9d-4387-ba33-96d28aad71dd
  • UNII 1C058IKG3B
  • RxCUI 1310525
  • RxCUI 1310533

What the source publishes

Labeler
Natco Pharma USA LLC
Active ingredients
Teriflunomide
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69339-170_70bc9344-abbf-4aca-96c0-7f10cfe9aae4
{
  "name": "Teriflunomide",
  "splId": "70bc9344-abbf-4aca-96c0-7f10cfe9aae4",
  "labels": [
    {
      "setId": "8219b4a2-fb9d-4387-ba33-96d28aad71dd",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8219b4a2-fb9d-4387-ba33-96d28aad71dd",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8219b4a2-fb9d-4387-ba33-96d28aad71dd"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Natco Pharma USA LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (69339-170-03)",
      "package_ndc": "69339-170-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240102"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (69339-170-09)",
      "package_ndc": "69339-170-09",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240102"
    },
    {
      "sample": false,
      "description": "2 BLISTER PACK in 1 CARTON (69339-170-93)  / 30 TABLET in 1 BLISTER PACK",
      "package_ndc": "69339-170-93",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230617"
    }
  ],
  "productId": "69339-170_70bc9344-abbf-4aca-96c0-7f10cfe9aae4",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "69339-170",
  "deaSchedule": null,
  "genericName": "Teriflunomide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TERIFLUNOMIDE",
      "strength": "14 mg/1"
    }
  ],
  "applicationNumber": "ANDA209555",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230617",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000185502",
      "N0000185501"
    ],
    "upc": [
      "0369339170090",
      "0369339169032",
      "0369339169094"
    ],
    "unii": [
      "1C058IKG3B"
    ],
    "rxcui": [
      "1310525",
      "1310533"
    ],
    "spl_set_id": [
      "8219b4a2-fb9d-4387-ba33-96d28aad71dd"
    ],
    "pharm_class_epc": [
      "Pyrimidine Synthesis Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Dihydroorotate Dehydrogenase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Natco Pharma USA LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69339-170_70bc9344-abbf-4aca-96c0-7f10cfe9aae4"